NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE104899 Query DataSets for GSE104899
Status Public on Apr 03, 2019
Title Bassoon proteinopathy drives neurodegeneration in multiple sclerosis
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Other
Summary During the course of multiple sclerosis (MS), inflammatory insults drive neuro-axonal loss and disability progression. However, pathways that guide neurons toward survival or death during central nervous system (CNS) inflammation are largely unexplored. Here we show that somatic deposition of the presynaptic protein bassoon (Bsn) in inflamed neurons directly contributes to neurodegeneration in MS. By comparing neuron-specific RNA-seq of healthy mice to mice undergoing experimental autoimmune encephalomyelitis (EAE), the animal model of MS, we identified key components of neurodegenerative pathways, including reduced mitochondrial ATP synthesis and increased protein catabolism. These changes were accompanied by neuronal induction and deposition of the intrinsically disordered protein Bsn in both EAE and in patients with MS. Somatic Bsn also accumulated in Bsn-overexpressing Neuro-2a (N2a) cells and single cell RNA-seq revealed dose-dependent repression of energy metabolism and induction of the unfolded protein response, reminiscent of our in vivo findings. Furthermore, Bsn overexpression in N2a cells or in Drosophila melanogaster neurons led to decreased survival and shortened lifespan, respectively. Conversely, genetic disruption of Bsn in mice was neuroprotective, with reduced neuro-axonal injury and clinical disability during EAE, establishing a toxic gain-of-function of Bsn during CNS inflammation. Our study provides systemic insights into neuronal responses to inflammation and identifies protein accumulation as a generic pathomechanism uniting primary and inflammatory neurodegeneration. Moreover, it offers a new explanation and possible treatment strategy to halt disability progression in MS, irrespective of immunotherapies.
 
Overall design Refer to individual Series
 
Citation(s) 31011226, 39145444
Submission date Oct 12, 2017
Last update date Sep 12, 2024
Contact name Manuel A Friese
E-mail(s) manuel.friese@zmnh.uni-hamburg.de
Organization name Universitätsklinikum Hamburg-Eppendorf
Department Institut für Neuroimmunologie und Multiple Sklerose
Street address Falkenried 94
City Hamburg
ZIP/Postal code 20251
Country Germany
 
Platforms (2)
GPL13112 Illumina HiSeq 2000 (Mus musculus)
GPL17021 Illumina HiSeq 2500 (Mus musculus)
Samples (21)
GSM2809697 SC-Healthy-rep1
GSM2809698 SC-Healthy-rep2
GSM2809699 SC-Healthy-rep3
This SuperSeries is composed of the following SubSeries:
GSE104897 TRAP-seq of spinal cord motor neurons in EAE versus healthy mice
GSE104898 Drop-seq of N2a cells transfected with Bsn
Relations
BioProject PRJNA414103

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE104899_RAW.tar 9.0 Mb (http)(custom) TAR (of TXT)
SRA Run SelectorHelp

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap